Reuters: Regulatory News: Nordion explores strategic alternatives

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Nordion explores strategic alternatives Jan 28th 2013, 12:27 Mon Jan 28, 2013 7:27am EST Jan 28 (Reuters) - Medical isotopes provider Nordion Inc said it has initiated a review of its strategic alternatives, almost four months after it suspended its dividend as an arbitration panel rejected its claim for damages from its main supplier. No decision has been made to enter into any specific deal, and the Canadian company said it intends to continue with planned business activities throughout the review process. [ID: nBw285375a] Shares of the company, valued at about C$398 million, have lost 41 percent of their value since touching a year high of C$10.86 in September.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions